From 2018 to 2020, the marketing of Chinese-produced Class 1 new drugs entered the harvest period, with a total of 32 marketed (Chinese-produced Class 1 new drugs here refer to drugs registered under the classification of chemical drugs 1 and therapeutic.
Class 1 new drugs, Chinese-produced, marketing.According to statistics, the NMPA approved the marketing of 13 Class 1 new drugs and 17 biological products in the 17 years from 2001 to 2017. The number of innovative drugs approved was pitifully small.
New Player Joining the Chinese Class 1 New Drugs of DPP-4 Inhibitor Type, what will be Its Odds of Success in Marching into the Hypoglycemic Drug Market?